Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding

Chemistry. 2019 Feb 6;25(8):2019-2024. doi: 10.1002/chem.201804790. Epub 2019 Jan 8.

Abstract

Human prolyl hydroxylases are involved in the modification of transcription factors, procollagen, and ribosomal proteins, and are current medicinal chemistry targets. To date, there are few reports on inhibitors selective for the different types of prolyl hydroxylases. We report a structurally informed template-based strategy for the development of inhibitors selective for the human ribosomal prolyl hydroxylase OGFOD1. These inhibitors did not target the other human oxygenases tested, including the structurally similar hypoxia-inducible transcription factor prolyl hydroxylase, PHD2.

Keywords: 2-oxoglutarate oxygenase; OGFOD1; barbiturate; epigenetics; histone demethylases; inhibitors; medicinal chemistry.

MeSH terms

  • Carrier Proteins / antagonists & inhibitors
  • Drug Design
  • Humans
  • Nuclear Proteins / antagonists & inhibitors
  • Prolyl Hydroxylases* / metabolism
  • Prolyl-Hydroxylase Inhibitors* / chemistry
  • Prolyl-Hydroxylase Inhibitors* / metabolism
  • Prolyl-Hydroxylase Inhibitors* / pharmacology
  • Ribosomes / drug effects*
  • Ribosomes / metabolism
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Carrier Proteins
  • Nuclear Proteins
  • OGFOD1 protein, human
  • Prolyl-Hydroxylase Inhibitors
  • Prolyl Hydroxylases